We provide you with 20 years of free, institutional-grade data for AKRO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AKRO. Explore the full financial landscape of AKRO stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$8,073,745
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
Cheng Andrew | Sale | -31,796 | $42.99 | $1,367,037 | 2025-09-12 |
Cheng Andrew | Derivatives Exercise | 14,941 | 2025-09-12 | ||
White William Richard | Sale | -659 | $43.02 | $28,350 | 2025-09-12 |
Yale Catriona | Sale | -659 | $43.02 | $28,350 | 2025-09-12 |
Young Jonathan | Sale | -586 | $43.02 | $25,210 | 2025-09-12 |
Rolph Timothy | Sale | -553 | $43.02 | $23,790 | 2025-09-12 |
Rolph Timothy | Sale | -12,500 | $44.17 | $552,113 | 2025-09-10 |
Rolph Timothy | Derivatives Exercise | 12,500 | 2025-09-10 | ||
Young Jonathan | Sale | -12,500 | $45.78 | $572,200 | 2025-09-04 |
Young Jonathan | Derivatives Exercise | 12,500 | 2025-09-04 | ||
Gangloff Scott A. | Derivatives Exercise | 2,600 | 2025-08-19 | ||
Cheng Andrew | Sale | -30,000 | $48.07 | $1,442,100 | 2025-08-13 |
Young Jonathan | Sale | -12,500 | $47.72 | $596,513 | 2025-08-13 |
Young Jonathan | Derivatives Exercise | 12,500 | 2025-08-13 | ||
Henderson Jane | Sale | -3,000 | $47.46 | $142,371 | 2025-08-12 |
Henderson Jane | Derivatives Exercise | 3,000 | 2025-08-12 | ||
Rolph Timothy | Sale | -12,500 | $49.06 | $613,313 | 2025-08-07 |
Rolph Timothy | Derivatives Exercise | 12,500 | 2025-08-07 | ||
Yale Catriona | Sale | -10,000 | $52.87 | $528,650 | 2025-07-18 |
Yale Catriona | Derivatives Exercise | 10,000 | 2025-07-18 | ||
Cheng Andrew | Sale | -30,000 | $50.57 | $1,517,100 | 2025-07-11 |
Rolph Timothy | Sale | -12,500 | $50.93 | $636,650 | 2025-07-09 |
Rolph Timothy | Derivatives Exercise | 12,500 | 2025-07-09 | ||
Lamy Patrick | Sale | -2,000 | $52.88 | $105,760 | 2025-07-03 |
Gangloff Scott A. | Grant, award...etc | 299 | $23.87 | 2025-07-02 | |
Rolph Timothy | Grant, award...etc | 890 | $23.87 | 2025-07-02 | |
Cheng Andrew | Grant, award...etc | 890 | $23.87 | 2025-07-02 | |
Lamy Patrick | Grant, award...etc | 193 | $23.87 | 2025-07-02 | |
Young Jonathan | Grant, award...etc | 890 | $23.87 | 2025-07-02 | |
White William Richard | Grant, award...etc | 890 | $23.87 | 2025-07-02 | |
Yale Catriona | Grant, award...etc | 890 | $23.87 | 2025-07-02 | |
White William Richard | Sale | -1,634 | $54.84 | $89,609 | 2025-06-20 |
Young Jonathan | Sale | -1,453 | $54.84 | $79,683 | 2025-06-20 |
Cheng Andrew | Sale | -6,620 | $54.84 | $363,041 | 2025-06-20 |
Rolph Timothy | Sale | -1,129 | $54.84 | $61,914 | 2025-06-20 |
Gangloff Scott A. | Sale | -848 | $54.84 | $46,504 | 2025-06-20 |
Yale Catriona | Sale | -11,633 | $53.78 | $625,623 | 2025-06-20 |
Yale Catriona | Derivatives Exercise | 10,000 | 2025-06-20 | ||
Lamy Patrick | Sale | -2,875 | $53.82 | $154,724 | 2025-06-20 |
Lamy Patrick | Derivatives Exercise | 2,000 | 2025-06-20 | ||
Lamy Patrick | Sale | -919 | $54 | $49,625 | 2025-06-12 |
Young Jonathan | Sale | -2,493 | $53.99 | $134,605 | 2025-06-12 |
Rolph Timothy | Sale | -2,358 | $54 | $127,323 | 2025-06-12 |
White William Richard | Sale | -2,804 | $53.99 | $151,402 | 2025-06-12 |
Cheng Andrew | Sale | -37,837 | $53.76 | $2,034,117 | 2025-06-12 |
Yale Catriona | Sale | -2,803 | $54 | $151,351 | 2025-06-12 |
Rolph Timothy | Sale | -37,500 | $53.37 | $2,001,488 | 2025-06-09 |
Rolph Timothy | Derivatives Exercise | 37,500 | 2025-06-09 | ||
Heyman Tomas J. | Grant, award...etc | 9,398 | 2025-06-05 | ||
Judy Chou | Grant, award...etc | 9,398 | 2025-06-05 | ||
Graham G. Walmsley | Grant, award...etc | 9,398 | 2025-06-05 | ||
Henderson Jane | Grant, award...etc | 9,398 | 2025-06-05 | ||
Iwicki Mark T | Grant, award...etc | 9,398 | 2025-06-05 | ||
Xu Yuan | Grant, award...etc | 9,398 | 2025-06-05 | ||
Harrison Seth Loring | Grant, award...etc | 9,398 | 2025-06-05 | ||
Lamy Patrick | Sale | -4,000 | $49.4 | $197,592 | 2025-06-04 |
Lamy Patrick | Derivatives Exercise | 4,000 | 2025-06-04 | ||
Lamy Patrick | Sale | -4,000 | $50 | $200,000 | 2025-05-23 |
Lamy Patrick | Derivatives Exercise | 4,000 | 2025-05-23 | ||
Yale Catriona | Sale | -10,000 | $38.2 | $381,990 | 2025-05-19 |
Yale Catriona | Derivatives Exercise | 10,000 | 2025-05-19 | ||
Cheng Andrew | Sale | -30,000 | $41 | $1,230,000 | 2025-05-13 |
Lamy Patrick | Sale | -8,000 | $42.31 | $338,472 | 2025-05-09 |
Lamy Patrick | Derivatives Exercise | 8,000 | 2025-05-09 | ||
Rolph Timothy | Sale | -12,500 | $42.26 | $528,300 | 2025-05-08 |
Rolph Timothy | Derivatives Exercise | 12,500 | 2025-05-08 | ||
Rolph Timothy | Sale | -6,250 | $41.03 | $256,438 | 2025-04-28 |
Rolph Timothy | Derivatives Exercise | 6,250 | 2025-04-28 | ||
Yale Catriona | Sale | -9,073 | $37.8 | $342,987 | 2025-04-16 |
Yale Catriona | Derivatives Exercise | 9,073 | 2025-04-16 | ||
Cheng Andrew | Sale | -30,000 | $35.23 | $1,056,780 | 2025-04-11 |
Rolph Timothy | Sale | -6,250 | $35.36 | $220,975 | 2025-04-10 |
Rolph Timothy | Derivatives Exercise | 6,250 | 2025-04-10 | ||
Graham G. Walmsley | Open Market Purchase | 200,000 | $44.75 | 2025-03-27 | |
Yale Catriona | Sale | -10,000 | $44.7 | $446,970 | 2025-03-18 |
Yale Catriona | Derivatives Exercise | 10,000 | 2025-03-18 | ||
Rolph Timothy | Sale | -516 | $44.88 | $23,158 | 2025-03-14 |
White William Richard | Sale | -676 | $44.88 | $30,339 | 2025-03-14 |
Young Jonathan | Sale | -607 | $44.88 | $27,242 | 2025-03-14 |
Yale Catriona | Sale | -614 | $44.88 | $27,556 | 2025-03-14 |
Cheng Andrew | Sale | -1,738 | $44.88 | $78,001 | 2025-03-14 |
Cheng Andrew | Sale | -30,000 | $41.75 | $1,252,380 | 2025-03-12 |
Rolph Timothy | Sale | -12,500 | $44.4 | $555,013 | 2025-03-07 |
Rolph Timothy | Derivatives Exercise | 12,500 | 2025-03-07 | ||
Young Jonathan | Sale | -50,000 | $44.17 | $2,208,400 | 2025-03-05 |
Lamy Patrick | Sale | -1,000 | $48.09 | $48,090 | 2025-03-05 |
Lamy Patrick | Derivatives Exercise | 1,000 | 2025-03-05 | ||
Yale Catriona | Sale | -10,000 | $49.79 | $497,900 | 2025-02-21 |
Yale Catriona | Derivatives Exercise | 10,000 | 2025-02-21 | ||
Cheng Andrew | Sale | -30,000 | $51.75 | $1,552,560 | 2025-02-11 |
Rolph Timothy | Sale | -18,750 | $56.33 | $1,056,094 | 2025-02-07 |
Rolph Timothy | Derivatives Exercise | 18,750 | 2025-02-07 | ||
Graham G. Walmsley | Open Market Purchase | 200,000 | $48 | 2025-02-07 | |
Young Jonathan | Sale | -10,000 | $53.56 | $535,650 | 2025-02-05 |
Yale Catriona | Sale | -102,664 | $55.16 | $5,662,536 | 2025-01-31 |
Yale Catriona | Derivatives Exercise | 102,664 | 2025-01-31 | ||
Lamy Patrick | Sale | -5,000 | $57.03 | $285,150 | 2025-01-29 |
Lamy Patrick | Derivatives Exercise | 4,000 | 2025-01-29 | ||
Lamy Patrick | Grant, award...etc | 234 | $19.69 | 2025-01-29 | |
Cheng Andrew | Sale | -30,000 | $54.56 | $1,636,800 | 2025-01-29 |
Rolph Timothy | Sale | -31,250 | $54.76 | $1,711,250 | 2025-01-29 |
Rolph Timothy | Derivatives Exercise | 31,250 | 2025-01-29 | ||
Cheng Andrew | Derivatives Exercise | 50,000 | 2025-01-27 | ||
Young Jonathan | Derivatives Exercise | 43,064 | 2025-01-27 | ||
Young Jonathan | Sale | -10,000 | $28.03 | $280,330 | 2025-01-06 |
Gangloff Scott A. | Grant, award...etc | 24,300 | 2024-12-18 | ||
Cheng Andrew | Grant, award...etc | 98,500 | 2024-12-18 | ||
Rolph Timothy | Grant, award...etc | 20,000 | 2024-12-18 | ||
Rolph Timothy | Sale | -3,800 | $31.1 | $118,172 | 2024-12-18 |
Rolph Timothy | Derivatives Exercise | 3,800 | 2024-12-18 | ||
Lamy Patrick | Sale | -1,000 | $29.13 | $29,130 | 2024-12-18 |
Lamy Patrick | Grant, award...etc | 17,400 | 2024-12-18 | ||
Young Jonathan | Grant, award...etc | 24,300 | 2024-12-18 | ||
White William Richard | Grant, award...etc | 24,300 | 2024-12-18 | ||
Yale Catriona | Sale | -9,074 | $29.11 | $264,117 | 2024-12-18 |
Yale Catriona | Derivatives Exercise | 9,074 | 2024-12-18 | ||
Yale Catriona | Grant, award...etc | 24,300 | 2024-12-18 | ||
White William Richard | Sale | -2,817 | $30.79 | $86,735 | 2024-12-12 |
Cheng Andrew | Sale | -7,855 | $30.79 | $241,855 | 2024-12-12 |
Rolph Timothy | Derivatives Exercise | 2,450 | 2024-12-12 | ||
Rolph Timothy | Sale | -4,818 | $30.79 | $148,346 | 2024-12-12 |
Yale Catriona | Sale | -2,810 | $30.79 | $86,520 | 2024-12-12 |
Lamy Patrick | Sale | -925 | $30.79 | $28,481 | 2024-12-12 |
Young Jonathan | Sale | -2,503 | $30.79 | $77,067 | 2024-12-12 |
Young Jonathan | Sale | -10,000 | $32.13 | $321,310 | 2024-12-04 |
Cheng Andrew | Sale | -25,000 | $32.09 | $802,250 | 2024-12-04 |
Cheng Andrew | Derivatives Exercise | 25,000 | 2024-12-04 | ||
Yale Catriona | Sale | -9,061 | $27.69 | $250,935 | 2024-11-19 |
Yale Catriona | Derivatives Exercise | 9,061 | 2024-11-19 | ||
Yale Catriona | Sale | -10,000 | $35.19 | $351,890 | 2024-11-08 |
Yale Catriona | Derivatives Exercise | 10,000 | 2024-11-08 | ||
Young Jonathan | Sale | -50,716 | $31.25 | $1,585,078 | 2024-11-05 |
Young Jonathan | Derivatives Exercise | 40,716 | 2024-11-05 | ||
Cheng Andrew | Sale | -108,366 | $31.47 | $3,410,495 | 2024-11-05 |
Cheng Andrew | Derivatives Exercise | 108,366 | 2024-11-05 | ||
Yale Catriona | Sale | -20,000 | $32.53 | $650,520 | 2024-11-01 |
Yale Catriona | Derivatives Exercise | 20,000 | 2024-11-01 | ||
Cheng Andrew | Sale | -91,634 | $31.14 | $2,853,116 | 2024-10-18 |
Cheng Andrew | Derivatives Exercise | 91,634 | 2024-10-18 | ||
Yale Catriona | Sale | -20,961 | $30.5 | $639,227 | 2024-10-16 |
Yale Catriona | Derivatives Exercise | 19,825 | 2024-10-16 | ||
Young Jonathan | Sale | -40,000 | $30.15 | $1,206,080 | 2024-10-16 |
Young Jonathan | Derivatives Exercise | 40,000 | 2024-10-16 | ||
Young Jonathan | Sale | -10,000 | $28.18 | $281,770 | 2024-10-03 |
Yale Catriona | Sale | -5,500 | $27.65 | $152,086 | 2024-09-23 |
Yale Catriona | Derivatives Exercise | 5,500 | 2024-09-23 | ||
Yale Catriona | Sale | -8,393 | $27.52 | $230,933 | 2024-09-18 |
Yale Catriona | Derivatives Exercise | 8,393 | 2024-09-18 | ||
Rolph Timothy | Sale | -537 | $26.18 | $14,059 | 2024-09-13 |
Cheng Andrew | Sale | -1,738 | $26.18 | $45,501 | 2024-09-13 |
Yale Catriona | Sale | -637 | $26.18 | $16,677 | 2024-09-13 |
White William Richard | Sale | -639 | $26.18 | $16,729 | 2024-09-13 |
Young Jonathan | Sale | -568 | $26.18 | $14,870 | 2024-09-13 |
Young Jonathan | Sale | -5,000 | $26.42 | $132,095 | 2024-09-05 |
Yale Catriona | Sale | -949 | $27.61 | $26,206 | 2024-09-05 |
Yale Catriona | Derivatives Exercise | 949 | 2024-09-05 | ||
White William Richard | Sale | -98,334 | $27.21 | $2,675,766 | 2024-08-29 |
White William Richard | Derivatives Exercise | 98,334 | 2024-08-29 | ||
Yale Catriona | Sale | -14,051 | $27.53 | $386,782 | 2024-08-28 |
Yale Catriona | Derivatives Exercise | 14,051 | 2024-08-28 | ||
Cheng Andrew | Derivatives Exercise | 24,538 | 2024-08-20 | ||
Young Jonathan | Sale | -5,000 | $26.44 | $132,200 | 2024-08-02 |
White William Richard | Sale | -161,855 | $28.01 | $4,533,559 | 2024-07-25 |
White William Richard | Derivatives Exercise | 161,855 | 2024-07-25 | ||
White William Richard | Sale | -34,811 | $28.05 | $976,274 | 2024-07-18 |
White William Richard | Derivatives Exercise | 29,803 | 2024-07-18 | ||
Young Jonathan | Sale | -5,000 | $23.4 | $117,020 | 2024-07-02 |
Young Jonathan | Grant, award...etc | 1,064 | $19.94 | 2024-07-02 | |
Rolph Timothy | Grant, award...etc | 1,064 | $19.94 | 2024-07-02 | |
Yale Catriona | Grant, award...etc | 1,064 | $19.94 | 2024-07-02 | |
Cheng Andrew | Grant, award...etc | 1,064 | $19.94 | 2024-07-02 | |
Lamy Patrick | Grant, award...etc | 221 | $19.94 | 2024-07-02 | |
Cheng Andrew | Sale | -7,894 | $22.64 | $178,728 | 2024-06-13 |
Lamy Patrick | Sale | -569 | $22.64 | $12,883 | 2024-06-13 |
Young Jonathan | Sale | -2,516 | $22.64 | $56,965 | 2024-06-13 |
Rolph Timothy | Sale | -2,380 | $22.64 | $53,886 | 2024-06-13 |
White William Richard | Sale | -2,831 | $22.64 | $64,094 | 2024-06-13 |
Yale Catriona | Sale | -2,825 | $22.64 | $63,961 | 2024-06-13 |
The information provided in this report about AKRO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Akero Therapeutics, Inc(NASDAQ:AKRO)Â


Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. Its lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protec...
Website: http://www.akerotx.com
Founded: 2017
IPO Price: $16Â (Jun 20, 2019)
Full Time Employees: 16
CEO: Andrew Cheng Â
Sector: Healthcare
Industry: Biotechnology